jimi

Article Details

Vol. 5 No. 2 (2026): Maret

Articles

HoLEP vs TURP in Benign Prostatic Hyperplasia: A Systematic Review

K Kevin Aldenio Hatma Krista N Nur Budiono
20 March 2026 Vol. 5 No. 2 (2026): Maret https://doi.org/10.35912/jimi.v5i2.6452
Abstract
20 Mar 2026

Purpose: This review evaluates the efficacy, safety, and durability of HoLEP versus TURP, addressing the research gap concerning their comparative long-term stability and performance across varying prostate volumes. The study focuses on functional outcomes, complication profiles, and the scalability of each technique.

Research Methodology: A systematic search (2020–2025) identified RCTs and meta-analyses comparing HoLEP and TURP in BPH patients. Parameters analyzed included IPSS, Qmax, PVR, perioperative outcomes, and reoperation rates.

Results: Both procedures show comparable functional gains. However, HoLEP offers a superior perioperative profile, significantly lower bleeding risk, and higher long-term durability. Furthermore, HoLEP’s efficacy is independent of prostate size, whereas TURP efficiency diminishes in larger glands. Conclusions: Despite a steeper learning curve, HoLEP’s safety and versatility position it as the primary modern surgical standard. TURP remains a relevant alternative depending on institutional facilities.

Conclusions: Despite having a longer learning curve, HoLEP is worthy of consideration as the primary choice in modern surgical management of BPH, while TURP remains relevant in certain conditions and facilities.

Limitations: Limitations of this systematic review are the heterogeneity of study designs, populations, and follow-up durations, which may affect the comparability of results.

Contributions: This review provides a contemporary evidence-based guide for clinicians in selecting optimal surgical interventions.

Keywords: Benign Prostatic Hyperplasia HoLEP Long-Term Outcomes Perioperative Outcomes TURP
How to Cite
“
Krista, K. A. H., & Budiono, N. (2026). HoLEP vs TURP in Benign Prostatic Hyperplasia: A Systematic Review. Jurnal Ilmu Medis Indonesia, 5(2), 85–94. https://doi.org/10.35912/jimi.v5i2.6452
Endnote/Zotero/Mendeley (RIS) BibTeX
References
  1. Adriansyah, I. A., Afriansyah, A., Siregar, M. A. R., Purnomo, N., Mirza, H., & Seno, D. H. (2021). Efficacy of holmium laser enucleation of the prostate in patients with detrusor underactivity: systematic review and meta-analysis. African Journal of Urology, 27(1). doi:10.1186/s12301-021-00230-1
  2. Altuntas, T., Sener, T. E., Sahak, M. Y., Dogan, K. A., Asker, O. F., & Tanidir, Y. (2026). Comparison of TURP versus HoLEP: Is 80 g a reliable cut off? Journal of Clinical Urology, 19(1), 122-130. doi:https://doi.org/10.1177/20514158251315799
  3. Basirun, B. (2024). Effects of TURP Surgery on BPH Patients. International Journal of Advanced Multidisciplinary Research and Studies, 4(1), 1033-1036. doi:https://doi.org/10.62225/2583049X.2024.4.1.2336
  4. Bayraktar, N., & Ba?eskio?lu, A. B. (2024). Holmium Laser Enucleation of the Prostate (HoLEP) Versus Transurethral Resection of the Prostate (TURP) in Elderly Patients: Insights Into Recovery, Complications, and Risk Factors. Cureus, 16(12), e76384. doi:10.7759/cureus.76384
  5. Chen, F., Chen, Y., Zou, Y., Wang, Y., Wu, X., & Chen, M. (2023). Comparison of holmium laser enucleation and transurethral resection of prostate in benign prostatic hyperplasia: a systematic review and meta-analysis. Journal of International Medical Research, 51(8). doi:10.1177/03000605231190763
  6. Daryanto, B., Suryanullah, W. S., & Putra, P. Y. P. (2025). Holmium laser enucleation of the prostate versus transurethral resection of the prostate in treatment of benign prostatic hyperplasia: A meta-analysis of 13 randomized control trials. Current Urology, 19(1), 6-16. doi:10.1097/CU9.0000000000000257
  7. De Cillis, S., Amparore, D., Volpi, G., Checcucci, E., Cattaneo, G., Meziere, J., . . . Porpiglia, F. (2022). Functional Results after First- and Second-Generation Temporary Implantable Nitinol Device (TIND) for BPH: A Narrative Review of the Literature. Current Bladder Dysfunction Reports, 17, 104-114. doi:https://doi.org/10.1007/s11884-022-00644-9
  8. Deori, R., Thomas, R., Rajan, N., Somarajan, S., Bharti, M., & Ananthamurthy, V. B. (2025). Comparison of Outcomes after Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate. Journal of Clinical Medicine of Kazakhstan, 22(5), 38-43. doi:https://doi.org/10.23950/jcmk/17151
  9. Eliwa, A., Aldarraji, A., Abdelwahab, K., & Salem, A. (2025). Randomized prospective trial comparing ejaculatory preservation HoLEP versus standard HoLEP: the other face of the coin. World Journal of Urology, 43(145). doi:https://doi.org/10.1007/s00345-024-05418-y
  10. Elmansy, H., Abbas, L., Fathy, M., Hodhod, A., Shabana, W., Alkandari, A., . . . Shahrour, W. (2023). Top-down holmium laser enucleation of the prostate (HoLEP) versus traditional HoLEP for the treatment of benign prostatic hyperplasia (BPH): 1-year outcomes of a randomized controlled trial. Prostate Cancer and Prostatic Diseases, 27, 462-468. doi:https://doi.org/10.1038/s41391-023-00730-x
  11. Elmansy, H., Hodhod, A., Fathy, M., Violette, P. D., Elshafei, A., Zakaria, A. S., . . . Shahrour, W. (2023). Emergency holmium laser enucleation of the prostate (HoLEP): a novel approach in the management of refractory hematuria for patients with benign prostatic hyperplasia (BPH): a single-institution experience. World Journal of Urology, 41, 805-811. doi:https://doi.org/10.1007/s00345-023-04292-4
  12. Faraon, B., Garces, J., Ahmad, S., Mahmoud, S., Danzinger, M., Shabsigh, R., . . . Carpo, B. (2024). The impact of the treatment of benign prostatic hyperplasia with lower urinary tract symptoms on quality of life, a scoping literature review aided by AI. Journal of Men's Health, 22(2). doi:10.22514/jomh.2024.104
  13. Franco, J. V. A., Jung, J. H., Imamura, M., Borofsky, M., Omar, M. I., Liquitay, C. M. E., . . . Dahm, P. (2021). Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU International, 130, 142-156. doi:https://doi.org/10.1111/bju.15653
  14. Fuschi, A., Asimakopoulos, A. D., Scalzo, S., Martoccia, A., Salhi, Y. A., Suraci, P. P., . . . Pastore, A. L. (2022). B-TURP versus HoLEP: Peri-Operative Outcomes and Complications in Frail Elderly (>75 y.o.) Patients: A Prospective Randomized Study. Biomedics, 10(12), 3212. doi:https://doi.org/10.3390/biomedicines10123212
  15. Gao, Z., Wang, P., Liu, H., Ding, Y., Xu, L., Sun, Z., . . . Wang, R. (2025). Technological innovation of HoLEP: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. World Journal of Urology, 43(64). doi:https://doi.org/10.1007/s00345-024-05438-8
  16. Haile, E. S., Sotimehin, A. E., & Gill, B. C. (2024). Medical management of benign prostatic hyperplasia. Cleve Clin J Med., 91(3), 163-170. doi:10.3949/ccjm.91a.23027
  17. Halawani, A., Paterson, R., Zhong, T., Du, K., Ren, R., & Forbes, C. M. (2024). Risks and side effects in the medical management of benign prostatic hyperplasia. Prostate International, 12(2), 57-64. doi:https://doi.org/10.1016/j.prnil.2023.11.004
  18. Hasan, A. M., AbdelRazek, M., Ali, A. F., Alsaghier, O. M., Ahmed, A. A., & Alsahier, G. A. A. (2022). Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH. World Journal of Urology, 40, 483-487. doi:https://doi.org/10.1007/s00345-021-03882-4
  19. Hu, X., Miao, J., Xie, K., Yang, Y., Wang, Y., Zhang, X., . . . Wei, H. (2025). Clinical comparison of TURP, PVP and holep for small volume BPH. Scientific Report, 15, 34751. doi:https://doi.org/10.1038/s41598-025-18395-y
  20. Husted, M., Gray, D., Golding, S. E., & Hindley, R. (2022). Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia. Qualitative Health Research, 33(13), 1979-1992. doi:https://doi.org/10.1177/10497323221129262
  21. Lebani, B. R., Barcelos, A. d. S., Gouveia, D. S. e. S., Girotti, M. E., Remaille, E. P., Skaff, M., & Almeida, F. G. (2023). The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility. The Prostate, 83, 857-862. doi:doi:10.1002/pros.24526
  22. Lee, H., So, S., Chul, C. M., Cho, S. Y., Paick, J.-s., & Oh, S.-J. (2024). Clinical outcomes of holmium laser enucleation of the prostate: A large prospective registry-based patient cohort study under regular follow-up protocol. Investigative and Clinical Urology, 65(4), 361-364. doi:10.4111/icu.20240080
  23. Leslie, S. W., Chargui, S., & Stormont, G. (2023). Transurethral Resection of the Prostate. StatPearls [Internet]. doi:https://www.ncbi.nlm.nih.gov/books/NBK560884/
  24. Maheshwari, P. N., Goyal, A. S., Srivastava, P., Kolsawala, H. G., Agrawal, P. J., Bhatt, N. J., & Harne, S. G. (2025). IP19-26 TURP VS HoLEP for Large Benign Prostatic Adenoma: Comparison of Perioperative Outcomes and PSA Dynamics. Journal of Urology, 213(5S), e995. doi:https://doi.org/10.1097/01.JU.0001110064.72214.9d.26
  25. Mostafa, M. M., Khallaf, A., Khalil, M., Elgammal, M. A., & Mahdy, A. (2022). Efficacy and safety of TURP, HoLEP, and PVP in the management of OAB symptoms complicating BPH in patients with moderately enlarged prostates: A comparative study. Canadian Urological Association Journal, 17(1), E1-E7. doi:10.5489/cuaj.7905
  26. Ng, M., Leslie, S. W., & Baradhi, K. M. (2024). Benign Prostatic Hyperplasia. StatPearls [Internet]. doi:https://www.ncbi.nlm.nih.gov/books/NBK558920/
  27. Pogula, V. M. R., Galeti, E. H., Ahmad, I., & Kanchi, B. R. (2021). Comparative Evaluation of Post-TURP Complications in Patients with BPH Presenting with and Without Acute Urinary Retention. International Journal of Recent Surgical and Medical Sciences, 8(1), 39-43. doi: https://doi.org/10.1055/s-0041-1736446.
  28. Pyrgidis, N., Schulz, G. B., Weinhold, P., Atzler, M., Stadelmeier, L. F., Papadopoulos, I., . . . Keller, P. K. (2025). Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study. Prostate Cancer and Prostatic Diseases, 29(1), 138-143. doi:10.1038/s41391-025-00980-x
  29. Shah, Y. B., Im, B. H., Hochberg, A. R., Freudenburg, E. P., Jiang, J., Gao, B. M., . . . Das, A. K. (2025). The new gold standard for surgical management of BPH: an institutional experience with 1000 HoLEPs. Canadian Journal of Urology, 32(1), 15-19. doi:https://doi.org/10.32604/cju.2025.064708
  30. Siqueira, M. H. B. (2025). Risk factors for benign prostatic hyperplasia: a comprehensive review. Revista da Associacao Medica Brasileira (1992), 71 (6), e20250343. doi:https://doi.org/10.1590/1806-9282.20250343
  31. Song, S. H., Kim, J. H., Kim, J. K., Oh, J. J., Lee, S., Jeong, S. J., . . . Lee, H. (2022). Clinical benefits of retrograde bladder filling method prior to catheter removal after TURP for BPH: A prospective randomized trial. Investigative and Clinical Urology, 63(6), 656-662. doi:10.4111/icu.20220233
  32. Sun, F., Yao, H., Bao, X., Wang, X., Wang, D., Zhang, D., . . . Wu, J. (2022). The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis. American Journal of Men's Health, 16(4). doi:https://doi.org/10.1177/15579883221113203
  33. Swedan, Q. N., Alkhatib, A. A., Alwraikat, N. A., Elsharif, R. N., Salameh, M., Badran, O., . . . Shahin, H. R. (2025). Comparative Effectiveness and Safety of TURP, HoLEP, and Rezum for Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Journal of Neonatal Surgery, 14(295), 165-177. doi:https://doi.org/10.63682/jns.v14i29S.6733
  34. Wei, H., Zhu, C., Huang, Q., Yang, J., Li, Y.-T., Zhang, Y.-G., . . . Zi, H. Z. (2025). Global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021 and projection to 2035. BMC Urology, 25(1), 34. doi:https://doi.org/10.1186/s12894-025-01715-9
  35. Xiang, J., Zheng, Y., Chen, D., Zheng, Y., Zhang, J., Chang, D., & Chang, C. (2025). The pathogenesis of benign prostatic hyperplasia and the roles of Prdx3, oxidative stress, pyroptosis and autophagy:a review. Frontiers in Oncology, 15, 1579539. doi:https://doi.org/10.3389/fonc.2025.1579539
  36. Xie, Z., Liu, X., Hu, Z., & Dong, C. (2024). Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). BMC Public Health, 24(1121). doi:https://doi.org/10.1186/s12889-024-18618-3
  37. Xu, G., Dai, G., Huang, Z., Guan, Q., Du, C., & Xu, X. (2024). The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy. Research and Reports in Urology, 16, 205-214. doi:10.2147/RRU.S477396
  38. Yu, J., Jeong, B. C., Jeon, S. S., Lee, S. W., & Lee, K.-S. (2021). Comparison of Efficacy of Different Surgical Techniques for Benign Prostatic Obstruction. International Neurology Journal, 25(3252-262). doi:10.5213/inj.2040314.157
  39. Zubair, A., Davis, S., Balogun, D. I., Nwokeocha, E., Chiedozie, C.-a., & Damilola, J. (2022). A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa. Cureus, 14(11), e31135. doi:10.7759/cureus.31135
License & Copyright
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Most read articles by the same author(s)